Literature DB >> 15599967

Computer-assisted medication review for asthmatic patients as a basis for intervention. Constructing and validating an algorithmic computer instrument in pharmacy practice.

Ada G G Stuurman-Bieze1, Paul B van den Berg, T F J Tromp, Lolkje T W de Jong-van den Berg.   

Abstract

OBJECTIVE: To construct and validate a computer instrument that identifies asthma patients receiving--theoretically--suboptimal drug therapy in community pharmacies, by the use of patient medication records. This selection enables the pharmacist to assist these patients in using medicines appropriately.
METHODS: According to Dutch asthma guidelines which describe a stepwise approach and in order to define correct profiles for the use at each level of these guidelines, the optimum use of drugs in the different levels in asthma treatment was expressed in defined daily doses (DDDs) per pharmacological drug-group during a period of one year. An algorithmic computer instrument was developed to select patients with medication use deviant from these profiles. By using nine different selection profiles, the computer instrument stratified patients according to the medication records filed in the pharmacy computer. Patient medication records in four community pharmacies were investigated to validate the selection profiles as indicators for theoretically suboptimal drug use by asthma patients. The validation was performed by comparing the professional judgement of participating pharmacists with the selections made by the computer. MAIN OUTCOME MEASURE: Positive predictive value and negative predictive value of the selection made by algorithmic computer instrument. Rate of false-positive results.
RESULTS: The computer instrument identified asthma patients using theoretically suboptimal drug therapy with approximately 95% predictive value compared with the professional judgement of the pharmacists. The rate of false-positive results was 5%.
CONCLUSION: The results of the algorithmic computer instrument and the professional judgement of the pharmacists are in close agreement. The instrument will be utilised in further research in the IPMP study (Interventions on the principle of Pulmonary Medication Profiles) investigating the role of Dutch community pharmacists in counselling patients who are at risk of suboptimal drug use in the treatment of their asthma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599967     DOI: 10.1023/b:phar.0000042926.99705.61

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  16 in total

1.  Computer-based models to identify high-risk adults with asthma: is the glass half empty of half full?

Authors:  T A Lieu; A M Capra; C P Quesenberry; G R Mendoza; M Mazar
Journal:  J Asthma       Date:  1999-06       Impact factor: 2.515

2.  [Knowledge about drugs used by adult patients with asthma for self-treatment].

Authors:  J J Klein; J van der Palen; E R Seydel; A H Kerkhoff
Journal:  Ned Tijdschr Geneeskd       Date:  1998-03-28

3.  Validation of pharmacy records in drug exposure assessment.

Authors:  H S Lau; A de Boer; K S Beuning; A Porsius
Journal:  J Clin Epidemiol       Date:  1997-05       Impact factor: 6.437

Review 4.  The assessment of refill compliance using pharmacy records: methods, validity, and applications.

Authors:  J F Steiner; A V Prochazka
Journal:  J Clin Epidemiol       Date:  1997-01       Impact factor: 6.437

5.  Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study.

Authors:  K F Rabe; P A Vermeire; J B Soriano; W C Maier
Journal:  Eur Respir J       Date:  2000-11       Impact factor: 16.671

6.  Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma.

Authors:  T Haahtela; M Järvinen; T Kava; K Kiviranta; S Koskinen; K Lehtonen; K Nikander; T Persson; K Reinikainen; O Selroos
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

7.  The effects of a pharmacy-based intervention on the knowledge and attitudes of asthma patients.

Authors:  U Närhi; M Airaksinen; P Tanskanen; H Enlund
Journal:  Patient Educ Couns       Date:  2001-05

8.  Inhaled steroids and the risk of hospitalization for asthma.

Authors:  J G Donahue; S T Weiss; J M Livingston; M A Goetsch; D K Greineder; R Platt
Journal:  JAMA       Date:  1997-03-19       Impact factor: 56.272

9.  [Poor technique in the use of inhalation drugs by patients with chronic bronchitis/pulmonary emphysema].

Authors:  J van der Palen; J J Klein; A H Kerkhoff
Journal:  Ned Tijdschr Geneeskd       Date:  1994-07-09

10.  A general method of compliance assessment using centralized pharmacy records. Description and validation.

Authors:  J F Steiner; T D Koepsell; S D Fihn; T S Inui
Journal:  Med Care       Date:  1988-08       Impact factor: 2.983

View more
  4 in total

1.  The pharmacists' potential to provide targets for interventions to optimize pharmacotherapy in patients with asthma.

Authors:  J F M van Boven; E G Hiddink; A G G Stuurman-Bieze; C C M Schuiling-Veninga; M J Postma; S Vegter
Journal:  Int J Clin Pharm       Date:  2013-07-26

2.  Complex pharmaceutical care intervention in pulmonary care: part B. Patient opinion and process survey.

Authors:  Ada G G Stuurman-Bieze; Mirjam E A P Kokenberg; Hilde Tobi; Willem O de Boer; Jasperien E van Doormaal; Lolkje T W Jong-van den de Berg; Th F J Tromp
Journal:  Pharm World Sci       Date:  2005-10

3.  Complex pharmaceutical care intervention in pulmonary care: part A. The process and pharmacists' professional satisfaction.

Authors:  Ada G G Stuurman-Bieze; Willem O de Boer; Mirjam E A P Kokenberg; Jacqueline G Hugtenburg; Lolkje T W de Jong-van den Berg; Th F J Tromp
Journal:  Pharm World Sci       Date:  2005-10

4.  Adherence to guideline recommendations for asthma care in community pharmacies: actual and needed performance.

Authors:  Esther Kuipers; Michel Wensing; Elaine Wong-Go; Bernard J G Daemen; Peter A G M De Smet; Martina Teichert
Journal:  NPJ Prim Care Respir Med       Date:  2019-07-11       Impact factor: 2.871

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.